Garabet Yeretssian is director of the Helmsley Charitable Trust’s Crohn’s Disease Program, which supports impactful ideas and mobilizes a global community committed to improving the lives of Crohn’s disease patients while pursuing a cure. Prior to joining Helmsley, Yeretssian was an assistant professor in the Immunology and Tisch Cancer Institutes at the Icahn School of Medicine at Mount Sinai, where he led a research team investigating the implication of innate immune and cell death mechanisms in inflammatory bowel diseases, Crohn’s disease, colorectal cancer, and other gastrointestinal disorders. Previously, he was a postdoctoral fellow and later on an associate researcher at McGill University, studying host-microbe interactions at gut mucosal surfaces.
